<DOC>
	<DOCNO>NCT00374231</DOCNO>
	<brief_summary>To determine safety efficacy early corticosteroid discontinuation liver transplant recipients 90 day post transplant , utilize combination two drug ( tacrolimus mycophenolate mofetil ) maintenance immunosuppressant therapy .</brief_summary>
	<brief_title>Single Center Pilot Study Corticosteroid Discontinuation Liver Transplant Recipients</brief_title>
	<detailed_description>To determine safety efficacy early corticosteroid discontinuation liver transplant recipients 90 day post transplant , utilize combination two drug ( tacrolimus mycophenolate mofetil ) maintenance immunosuppression therapy .</detailed_description>
	<mesh_term>Prednisone</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<criteria>Greater 90 day post transplant . Free rejection within last 30 day . Patient primary diagnosis AIH evaluate individual basis . Negative pregnancy test . Practicing acceptable method birth control . Capable provide write informed consent . Rejection within last 30 day . Patients AIH unable discontinue corticosteroid . Patients currently receive systemic corticosteroid medical disease physician feel discontinuation contraindicate . Known sensitivity contraindication tacrolimus MMF . Kidney , pancreas , islet , heart , lung , small bowel transplant recipient . Pregnant lactating .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Liver</keyword>
	<keyword>Transplant</keyword>
	<keyword>Corticosteroid withdrawal</keyword>
	<keyword>Tacrolimus</keyword>
	<keyword>CellCept</keyword>
	<keyword>MMF</keyword>
	<keyword>Mycophenolate mofetil</keyword>
</DOC>